Twitter Shreds Drug Profiteer as Price Rise Scandal Goes National

Personal Health

Former hedge-fund manager Martin Shkreli is coming under fire after Andrew Pollack published an unflattering profile of his company, Turing Pharmaceuticals, on Sunday.

The article hinged on the fact that Turing purchased Daraprim, used to treat life-threatening parasitic infections in pregnant women and immunocompromised individuals, and immediately raised the price of the drug from $13.50 per dosage to $750. Shkreli claimed that the drug is used so infrequently that it would have minimal impact on the health care system.

“This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,” he said, adding that most individuals on the drug are receiving doses for short periods of time, and that the new price better reflects the rarity with which it is prescribed.

“This is still one of the smallest pharmaceutical products in the world,” he said. “It really doesn’t make sense to get any criticism for this.”

Needless to say, not only does it make perfect sense for him to be receiving criticism “for this,” he’s getting quite a bit of it:





They no doubt approve of his favorite method of dealing with criticism — quoting rappers:


Watch Shkreli speak to Bloomberg Business about the reaction to his decision below:

Understand the importance of honest news ?

So do we.

The past year has been the most arduous of our lives. The Covid-19 pandemic continues to be catastrophic not only to our health - mental and physical - but also to the stability of millions of people. For all of us independent news organizations, it’s no exception.

We’ve covered everything thrown at us this past year and will continue to do so with your support. We’ve always understood the importance of calling out corruption, regardless of political affiliation.

We need your support in this difficult time. Every reader contribution, no matter the amount, makes a difference in allowing our newsroom to bring you the stories that matter, at a time when being informed is more important than ever. Invest with us.

Make a one-time contribution to Alternet All Access, or click here to become a subscriber. Thank you.

Click to donate by check.

DonateDonate by credit card
Donate by Paypal
{{ }}
@2022 - AlterNet Media Inc. All Rights Reserved. - "Poynter" fonts provided by